Taiwan
· Delayed Price · Currency is TWD Diamond Biofund Statistics
Total Valuation
Diamond Biofund has a market cap or net worth of TWD 33.93 billion. The enterprise value is 27.29 billion.
| Market Cap | 33.93B |
| Enterprise Value | 27.29B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Diamond Biofund has 850.35 million shares outstanding. The number of shares has increased by 10.68% in one year.
| Shares Outstanding | 850.35M |
| Shares Change (YoY) | +10.68% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 25.28% |
| Owned by Institutions (%) | 5.11% |
| Float | 178.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -17.37 |
| PB Ratio | 2.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.17 |
Financial Position
The company has a current ratio of 104.24, with a Debt / Equity ratio of 1.09.
| Current Ratio | 104.24 |
| Quick Ratio | 104.22 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -762.37 |
Financial Efficiency
Return on equity (ROE) is -19.25% and return on invested capital (ROIC) is -12.06%.
| Return on Equity (ROE) | -19.25% |
| Return on Assets (ROA) | -11.94% |
| Return on Capital (ROIC) | -12.06% |
| Revenue Per Employee | -68.05M |
| Profits Per Employee | -73.58M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.99% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -37.99% |
| 50-Day Moving Average | 40.72 |
| 200-Day Moving Average | 42.88 |
| Relative Strength Index (RSI) | 50.37 |
| Average Volume (20 Days) | 1,031,224 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Diamond Biofund had revenue of TWD -1.91 billion and -2.06 billion in losses. Loss per share was -2.49.
| Revenue | -1.91B |
| Gross Profit | -1.91B |
| Operating Income | -2.08B |
| Pretax Income | -2.06B |
| Net Income | -2.06B |
| EBITDA | -2.07B |
| EBIT | -2.08B |
| Loss Per Share | -2.49 |
Balance Sheet
The company has 6.77 billion in cash and 129.52 million in debt, giving a net cash position of 6.64 billion or 7.81 per share.
| Cash & Cash Equivalents | 6.77B |
| Total Debt | 129.52M |
| Net Cash | 6.64B |
| Net Cash Per Share | 7.81 |
| Equity (Book Value) | 11.93B |
| Book Value Per Share | 14.03 |
| Working Capital | 6.71B |
Cash Flow
In the last 12 months, operating cash flow was -4.39 billion and capital expenditures -31.49 million, giving a free cash flow of -4.42 billion.
| Operating Cash Flow | -4.39B |
| Capital Expenditures | -31.49M |
| Free Cash Flow | -4.42B |
| FCF Per Share | -5.20 |
Margins
| Gross Margin | n/a |
| Operating Margin | 109.03% |
| Pretax Margin | 108.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 232.01% |
Dividends & Yields
Diamond Biofund does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.68% |
| Shareholder Yield | -10.68% |
| Earnings Yield | -6.25% |
| FCF Yield | -13.03% |
Stock Splits
The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.18.
| Last Split Date | Aug 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.18 |